Crystalline Management »

Recro Pharma shares owned by Crystalline Management

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Crystalline Management from 13F filings

Historical chart of Crystalline Management investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Crystalline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Crystalline Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $560k 519k 1.08

More positions owned by Crystalline Management

Altair Engr Note 1.750% 6/1 (Principal)
Enerplus Corp (ERF)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Mountain & Co I Acquisitn Class A Ord (MCAA)
Monterey Cap Acquisition Cor Class A Com (MCAC)
Hollysys Automation Tchngy L SHS (HOLI)
Ap Acquisition Corp Cl A Ord Shs (APCA)
Global Star Acquisition Class A Com (GLST)
Axonics Modulation Technolog (AXNX)
Ix Acquisition Corp Class A Ord Shs (IXAQ)
Tlgy Acquisition Corporation Class A Ord Shs (TLGY)
Oca Acquisition Corp Com Cl A (OCAX)
Daseke (DSKE)
Learn Cw Investment Cor Cl A Ord Shs (LCW)
Hudson Acquisition I Corp Common Stock (HUDA)

View all positions for Crystalline Management

Top funds holding Recro Pharma

First Light Asset Management
Beryl Capital Management
AWM Investment Company
Vanguard Group
OV Management
Geode Capital Management
Trium Capital
Vazirani Asset Management
Skandinaviska Enskilda Banken AB
Crystalline Management
BlackRock
Clear Harbor Asset Management
FNY Investment Advisers
Samjo Management
Bridgeway Capital Management

View all funds holding Recro Pharma